ArticleForensic science international. Synergy2025
Fatal intoxication after oral ingestion of amphetamine: Two case reports.
Article in Forensic science international. Synergy, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Amphetamine is a stimulant that is abused worldwide and e.g. leads to hyperthermia [Brinkman et al., 2014], dizziness, insomnia, stomachaches and suppression of appetite [Callaway et al., 1994]. The most common production route of racemic (R-/S)-amphetamine is the Leuckart synthesis [United Nations Office on Drugs and Crime 2006, Hauser et al., 2018], where by-products like 4-methyl-5-phenylpyrimidine (4-M-5-PP), N,N-di (β-phenylisopropyl)amine (DPIA) and N-formylamphetamine (NFA) are incurred. We describe two cases in which 39 years old men died after oral intake of greater amounts of liquid amphetamine preparations. Body fluids (heart blood, femoral vein blood, urine, cerebrospinal fluid, vitreous humour, and stomach content), organ tissues (myocardium, lung, liver, gall bladder, brain and kidney) and skeletal muscle were examined for amphetamine and amphetamine by-products as well as for other substances e.g. alcohol and pharmaceuticals. Analysis were done via HPLC/DAD, LC/MS, GC/MS or GC/FID without or after fluid-fluid extraction. Amphetamine was detected in all biological materials, the highest concentrations were found in urine (2600 μg/ml, case 1) and stomach content (14,000 μg/g, case 2). The amphetamine by-product DPIA was found only in heart blood (case 2), while NFA and 4-M-5-PP could not be detected at all. Morphological findings and the toxicological results for (R-/S)- amphetamine, the amphetamine by-products, alcohol, other drugs and pharmaceuticals are shown for both cases. The amphetamine concentrations of both cases are compared and the distribution in the body is discussed. The toxicity of the amphetamine by-products on the human body remains unclear and is subject of further studies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.